Pfizer and Moderna Stocks: Down 30% and 27% – Buy and Holdby Terry Bingman 06.04.2024Pfizer and Moderna have struggled in the stock market, but Pfizer has a substantial pipeline of programs. Moderna's success is ...
Pfizer’s Debt Concerns Cast Doubt on Viking Therapeutics Acquisitionby Mark Eisenberg 01.04.2024Pfizer's interest in the weight loss market is uncertain due to its significant debt of over $70 billion and recent ...